Methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells
AssigneeResearch Development Foundation
InventorsSeema Sharma, Marc R. Montminy
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Development Foundation
InventorsSeema Sharma, Marc R. Montminy
Estimating the term…
One embodiment of the present invention provides a method of testing for compounds which may induce STF-1 transcription. Pancreatic islet cells which express the STF-1/lacz fusion gene are isolated and the effect of various compounds on STF-1 expression is measured by adding the compound of interest to STF-1/lacZ expressing cells. LacZ activity in control and treated cells is then quantitated by a colorimetric assay. Using this method, a large number of compounds can be screened and STF-1 inducing compounds can be identified readily. Another embodiment of the present invention provides a method of using the STF-1 promoter to mark insulin producing pancreatic islet cells in vivo. In this regard, the green fluorescent protein (GFP) served as an indicator. The introduction of the STF-1 green fluorescent protein transgene into pigs allows for the efficient and rapid recovery of insulin producing cells from the pancreas.
A method for determining an ability of a test compound to stimulate pancreatic islet cells to induce STF-1 transcription, comprising the steps of:
A method of marking insulin-producing pancreatic islet cells in vivo, comprising the steps of:
Dependencies are inferred from the claim text.